Boyd Koffman, MD
Neurology · Toledo, OHNPI 1609862762
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $621 of the $799 with a category attached, or 77.8%. 7 manufacturers reported payments, led by Novartis at 28.2% of the total. That places this record below the midpoint for neurology clinicians in OH, where the typical reported total is $970.
Across 62 payments — averaging $12.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$225
- Acorda Therapeutics, Inc$178
- EMD Serono, Inc.$171
- Amgen$101
- AbbVie$88
- Biogen$22
- plus $14 from 1 others
Across 31 payments — averaging $998.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- EMD Serono, Inc.$23K
- Novartis$8K
What the payments were for
- Speaking & faculty fees$17822%
- Food & beverage$62178%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 14 | $225 |
| Acorda Therapeutics, Inc | 8 | $178 |
| EMD Serono, Inc. | 28 | $171 |
| Amgen | 6 | $101 |
| AbbVie | 4 | $88 |
| Biogen | 1 | $22 |
| Pfizer | 1 | $14 |
How this compares
$799 in reported general payments places this provider in the 45th percentile of 702 neurology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CopaxoneGlatiramer Acetate | 23 | $144,044 |
| Kesimpta PenOfatumumab | 12 | $120,338 |
| Avonex Pen (4 Pack)Interferon Beta-1a | 12 | $115,092 |
| FingolimodFingolimod Hcl | 26 | $96,715 |
| Glatiramer Acetate | 21 | $76,438 |
| Dimethyl Fumarate | 33 | $58,001 |
| Dalfampridine ErDalfampridine | 26 | $5,032 |
| Baclofen | 117 | $2,169 |
| Gabapentin | 121 | $1,834 |
| Pregabalin | 52 | $1,826 |
| Ropinirole ErRopinirole Hcl | 15 | $1,450 |
| Pyridostigmine Bromide | 18 | $1,208 |
| AmantadineAmantadine Hcl | 28 | $1,058 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $933 |
| Modafinil | 28 | $821 |
Paid to pharmacies, not to this prescriber.
Other neurology in Toledo
- Lawrence ElmerToledo$687K
- Faizan HafeezToledo$337K
- Howard SchechtToledo$183K
- Aram ZabetiCincinnati$1.6M
- Kenneth MankowskiColumbus$1.4M
- Aaron BosterColumbus$1.2M
- Martin TaylorNew Albany$821K
- Jacqueline NicholasColumbus$743K
- Kenneth PugarCenterville$582K
- Brendan BauerSheffield Village$548K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.